Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial-Reference-Cited by-同舟云学术

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial

Published:2014-09 Issue:9948 Volume:384 Page:1118-1127
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rintoul Robert C,Ritchie Andrew J,Edwards John G,Waller David A,Coonar Aman S,Bennett Maxine,Lovato Eleonora,Hughes Victoria,Fox-Rushby Julia A,Sharples Linda D

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Continuing increase in mesothelioma mortality in Britain;Peto;Lancet,1995

2. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050;Hodgson;Br J Cancer,2005

3. The European mesothelioma epidemic;Peto;Br J Cancer,1999

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Short-Term Treatment-Related Symptoms and Quality of Life: Results From an International Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Pleural Effusion: A Multidisciplinary Approach;Open Respiratory Archives;2024-10

2. Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review;Current Oncology;2024-07-30

3. Malignant Pleural Mesothelioma;Challenges in Pleural Pathology - Diagnostics, Treatment and Research;2024-07-10

4. CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis;npj Precision Oncology;2024-06-29

5. Contemporary management of mesothelioma;Breathe;2024-06